Fenofibrate for COVID-19 and related complications as an approach to improve treatment outcomes: the missed key for Holy Grail
- 8 August 2022
- journal article
- review article
- Published by Springer Nature in Inflammation Research
- Vol. 71 (10-11) , 1159-1167
Abstract
Introduction Fenofibrate is an agonist of peroxisome proliferator activated receptor alpha (PPAR-α), that possesses anti-inflammatory, antioxidant, and anti-thrombotic properties. Fenofibrate is effective against a variety of viral infections and different inflammatory disorders. Therefore, the aim of critical review was to overview the potential role of fenofibrate in the pathogenesis of SARS-CoV-2 and related complications. Results By destabilizing SARS-CoV-2 spike protein and preventing it from binding angiotensin-converting enzyme 2 (ACE2), a receptor for SARS-CoV-2 entry, fenofibrate can reduce SARS-CoV-2 entry in human cells Fenofibrate also suppresses inflammatory signaling pathways, which decreases SARS-CoV-2 infection-related inflammatory alterations. In conclusion, fenofibrate anti-inflammatory, antioxidant, and antithrombotic capabilities may help to minimize the inflammatory and thrombotic consequences associated with SARSCoV-2 infection. Through attenuating the interaction between SARS-CoV-2 and ACE2, fenofibrate can directly reduce the risk of SARS-CoV-2 infection. Conclusions As a result, fenofibrate could be a potential treatment approach for COVID-19 control.Keywords
Funding Information
- Universidade de Vigo (CISUG, CISUG, CISUG, CISUG, CISUG, CISUG, CISUG)
This publication has 85 references indexed in Scilit:
- Fenofibrate Reduces Mortality and Precludes Neurological Deficits in Survivors in Murine Model of Japanese Encephalitis Viral InfectionPLOS ONE, 2012
- The modulatory mechanisms of fenofibrate on human primary T cellsEuropean Journal of Pharmaceutical Sciences, 2010
- PPARα agonist fenofibrate protects the kidney from hypertensive injury in spontaneously hypertensive rats via inhibition of oxidative stress and MAPK activityBiochemical and Biophysical Research Communications, 2010
- Toll‐like receptor 4 mediates cross‐talk between peroxisome proliferator‐activated receptor γ and nuclear factor‐κB in macrophagesImmunology, 2008
- PPARα and PPARγ effectively protect against HIV‐induced inflammatory responses in brain endothelial cellsJournal of Neurochemistry, 2008
- Sulfatide Is Required for Efficient Replication of Influenza A VirusJournal of Virology, 2008
- Metabolism and cell biology of vitamin KThrombosis and Haemostasis, 2008
- NAD(P)H oxidase/nitric oxide interactions in peroxisome proliferator activated receptor (PPAR)α-mediated cardiovascular effectsMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 2005
- Early antithrombotic and anti-inflammatory effects of simvastatin versus fenofibrate in patients with hypercholesterolemiaThrombosis and Haemostasis, 2005
- Developmental expression of the type I diabetes related antigen sulfatide and sulfated lactosylceramide in mammalian pancreasJournal of Cellular Biochemistry, 2003